Article info
PostScript
Letter
N-of-1 trial of salbutamol in hyperkalaemic periodic paralysis
- Correspondence to Bas C Stunnenberg, Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Donders Center for Medical Neuroscience, Radboud University Medical Center, Radboudumc, Nijmegen 6500HB, Gelderland, The Netherlands; Bas.Stunnenberg{at}Radboudumc.nl
Citation
N-of-1 trial of salbutamol in hyperkalaemic periodic paralysis
Publication history
- Received February 9, 2021
- Accepted May 15, 2021
- First published June 10, 2021.
Online issue publication
November 16, 2021
Article Versions
- Previous version (10 June 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.